Posters

Direct-acting antiviral drugs used ın the treatment of HCV Increase cholesterol levels

Volume 30 · Issue Supplement 1 Publish Date: July 25, 2019
Full Text PDF
DOI
Osman Ozdogan
Mersin University Faculty of Medicine Gastroenterology Department Mersin Turkey
Serkan Yaras
Mersin University Faculty of Medicine Gastroenterology Department Mersin Turkey
Enver Ucbilek
Mersin University Faculty of Medicine Gastroenterology Department Mersin Turkey
Fehmi Ates
Mersin University Faculty of Medicine Gastroenterology Department Mersin Turkey
Orhan Sezgin
Mersin University Faculty of Medicine Gastroenterology Department Mersin Turkey
Engin Altintas
Mersin University Faculty of Medicine Gastroenterology Department Mersin Turkey
Ozdogan, O., Yaras, S., Ucbilek, E., Ates, F., Sezgin, O., & Altintas, E. (2019). Direct-acting antiviral drugs used ın the treatment of HCV Increase cholesterol levels. Turkish Journal of Gastroenterology, 30(Supplement 1), 69–69. https://doi.org/10.5152/tjg.2019.46
Full Text PDF

Abstract

INTRODUCTION: Aim is to investigate the effects of direct-acting antiviral (DAA) drugs on insulin resistance and lipid parameters in HCV treatment. METHODS: A total of 121 patients were included in the study. Fasting blood glucose (FBG), insulin level (insulin), insulin resistance, total cholesterol, HDL, LDL cholesterol and triglyceride levels were measured at 0, 1, 3, 6 and 12 months. RESULTS: HCV RNA levels were 3.394x103 ± 9.419x103 (min; 1255, max; 82.000 x103) IU / mL. 117 patients were genotype 1. According to months, FBG levels were 96 ± 12, 102 ± 17, 100 ± 15, 100 ± 14, 100 ± 14 mg / dL, and HOMA-IR was 2.93 ± 0.96, 4.73 ± 2.69, 4.6 ± 2.07, 3.38 ± 2.33, 3.17 ± 1.58, respectively. Especially, at the 1st month of the treatment, insulin and HOMA-IR levels were significantly higher than the initiation of treatment (p 0.05). CONCLUSION: DAA drugs used in the treatment of HCV infection increased IR, total cholesterol and LDL cholesterol levels during treatment

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 > >> 
Article Info
Published In
Journal Turkish Journal of Gastroenterology
Volume / Issue Volume 30 · Issue Supplement 1
Pages 69-69
History
Published Online July 25, 2019
Copyright
Affiliations
Osman Ozdogan
Mersin University Faculty of Medicine Gastroenterology Department Mersin Turkey
Serkan Yaras
Mersin University Faculty of Medicine Gastroenterology Department Mersin Turkey
Enver Ucbilek
Mersin University Faculty of Medicine Gastroenterology Department Mersin Turkey
Fehmi Ates
Mersin University Faculty of Medicine Gastroenterology Department Mersin Turkey
Orhan Sezgin
Mersin University Faculty of Medicine Gastroenterology Department Mersin Turkey
Engin Altintas
Mersin University Faculty of Medicine Gastroenterology Department Mersin Turkey
Cite this Article
Ozdogan, O., Yaras, S., Ucbilek, E., Ates, F., Sezgin, O., & Altintas, E. (2019). Direct-acting antiviral drugs used ın the treatment of HCV Increase cholesterol levels. Turkish Journal of Gastroenterology, 30(Supplement 1), 69–69. https://doi.org/10.5152/tjg.2019.46
Outlines